CITRO, VALENTINA
CITRO, VALENTINA
Dipartimento di Scienze della Salute
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma
2023 N. Platonova, E. Lazzari, M. Colombo, M. Falleni, D. Tosi, D. Giannandrea, V. Citro, L. Casati, D. Ronchetti, N. Bolli, A. Neri, F. Torricelli, L.A. Crews, C.H.M. Jamieson, R. Chiaramonte
Nanoplastic impact on bone microenvironment: A snapshot from murine bone cells
2023 D. Giannandrea, M. Parolini, V. Citro, B. De Felice, A. Pezzotta, N. Abazari, N. Platonova, M. Sugni, M. Chiu, A. Villa, E. Lesma, R. Chiaramonte, L. Casati
Extracellular Vesicles as an Innovative Tool for siRNA Delivery to Block the Pathological Communication between Tumor and Microenvironment.
2023 N. Abazari, D. Giannandrea, L. Casati, A. Villa, E. Crippa, N. Platonova, V. Citro, G. Sauro, P. Ciana, R. Chiaramonte
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way
2022 D. Giannandrea, N. Platonova, M. Colombo, M. Mazzola, V. Citro, R. Adami, F. Maltoni, S. Ancona, V. Dolo, I. Giusti, A. Basile, A. Pistocchi, L. Cantone, V. Bollati, L. Casati, E. Calzavara, M. Turrini, E. Lesma, R. Chiaramonte
Nanoplastics & health: taking a picture of bone cells
2021 L. Casati, D. Giannandrea, V. Citro, N. Platonova, M. Sugni Daniele Bottai, M. Parolini, R. Chiaramonte
The role of NOTCH2 in the Extracellular vesicles mediated communication in Multiple Myeloma: a focus on angiogenesis and osteoclastogenesis
2021 D. Giannandrea, N. Platonova, M. Colombo, V. Citro, R. Adami, F. Maltoni, S. Ancona, A. Basile, L. Cantone, V. Bollati, L. Casati, M. Turrini, E. Lesma, R. Chiaramonte
The role of NOTCH2 in the extracellular vesicles-mediated angiogenesis and osteoclastogenesis in multiple myeloma
2021 D. Giannandrea, N. Platonova, V. Citro, M. Colombo, M. Mazzola, R. Adami, F. Maltoni, L. Cantone, A. Pistocchi, V. Bollati, S. Ancona, E. Lesma, M. Turrini, R. Chiaramonte
The role of Notch pathway in the pro-tumorigenic activity of extracellular vesicles in multiple myeloma
2021 D. Giannandrea, M. Colombo, N. Platonova, V. Citro, M. Mazzola, A. Pistocchi, R. Adami, V. Dolo, I. Giusti, L. Cantone, V. Bollati, M. Turrini, R. Chiaramonte
Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis
2021 D. Giannandrea, V. Citro, E. Lesma, M. Bignotto, N. Platonova, R. Chiaramonte
Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study
2021 V. Sibilia, D. Bottai, R. Maggi, F. Pagani, R. Chiaramonte, D. Giannandrea, V. Citro, N. Platonova, L. Casati
Jagged ligands as new targets in multiple myeloma associated angiogenesis
2020 D. Giannandrea, M.T. Palano, N. Platonova, G. Gaudenzi, M. Falleni, D. Tosi, E. Lesma, V. Citro, M. Colombo, I. Saltarella, R. Ria, N. Amodio, E. Taiana, A. Neri, G. Vitale, R. Chiaramonte
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells
2020 M.T. Palano, D. Giannandrea, N. Platonova, G. Gaudenzi, M. Falleni, D. Tosi, E. Lesma, V. Citro, M. Colombo, I. Saltarella, R. Ria, N. Amodio, E. Taiana, A. Neri, G. Vitale, R. Chiaramonte
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease
2020 S. Seemann, M. Ernst, C. Cimmaruta, S. Struckmann, C. Cozma, D. Koczan, A.M. Knospe, L.R. Haake, V. Citro, A.U. Brauer, G. Andreotti, M.V. Cubellis, G. Fuellen, A. Hermann, A.K. Giese, A. Rolfs, J. Lukas
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor
2019 F. Furlan, G. Eden, M. Archinti, R. Arnaudova, G. Andreotti, V. Citro, M.V. Cubellis, A. Motta, B. Degryse
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR
2018 G. Eden, M. Archinti, R. Arnaudova, G. Andreotti, A. Motta, F. Furlan, V. Citro, M.V. Cubellis, B. Degryse
The analysis of variants in the general population reveals that PMM2 is extremely tolerant to missense mutations and that diagnosis of PMM2-CDG can benefit from the identification of modifiers
2018 V. Citro, C. Cimmaruta, M. Monticelli, G. Riccio, B.H. Mele, M.V. Cubellis, G. Andreotti
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase
2018 C. Cimmaruta, V. Citro, G. Andreotti, L. Liguori, M.V. Cubellis, B. Hay Mele
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo
2018 F. Furlan, G. Eden, M. Archinti, R. Arnaudova, G. Andreotti, V. Citro, M.V. Cubellis, A. Motta, B. Degryse
In vitro enzyme measurement to test pharmacological Chaperone responsiveness in Fabry and Pompe Disease
2017 J. Lukas, A. Knospe, S. Seemann, V. Citro, M.V. Cubellis, A. Rolfs
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP : possible implications for the disease PMM2-CDG
2017 V. Citro, C. Cimmaruta, L. Liguori, G. Viscido, M.V. Cubellis, G. Andreotti